Glyco Expression Technologies

Glyco Expression Technologies is a private U.S. glycobiology tools and services company focused on high-level expression of glycosylated recombinant products in mammalian cells. The company commercializes a proprietary expression platform built around engineered mammalian cell lines, pGE expression vectors, and its Glo-Enzyme fusion protein strategy to produce active glyco-enzymes and other recombinant glycoproteins. Its business appears centered on research-use products and custom glycoprotein production services rather than therapeutic drug development. The company originated from the University of Georgia's Complex Carbohydrate Research Center and serves research and industry applications including glycan remodeling, chemo-enzymatic synthesis, structural biology, and biotherapeutic support work.